Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice

Behavioural Brain Research

Volumn 133, Issue 2, 2002, Pages 369-376

  Jain, Naveen K ^a   Patil, C S ^b   Kulkarni, Shrinivas K ^a   Singh, Amarjit ^b  

^a PANJAB UNIVERSITY   (India)

^b Panacea Biotec Ltd   (India)

Author keywords

Aging; Cognitive performance; Lipopolysaccharide; Non steroidal anti inflammatory drugs; Scopolamine

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; LIPOPOLYSACCHARIDE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SCOPOLAMINE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CENTRAL NERVOUS SYSTEM; COGNITION; CONTROLLED STUDY; DRUG DOSE; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; INFLAMMATION; LEARNING DISORDER; MALE; MAZE TEST; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TASK PERFORMANCE;

AGING; ANIMALS; ANXIETY; AVOIDANCE LEARNING; COGNITION DISORDERS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; GASTROINTESTINAL DISEASES; ISOENZYMES; LACTONES; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; MICE; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; MUSCULOSKELETAL EQUILIBRIUM; NAPROXEN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SCOPOLAMINE; SULFONAMIDES; SULFONES;

EID: 0037130374     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(02)00025-6     Document Type: Article

References (39)

1. Function and activation of NF-kappa B in the immune system
2. Platelet-activating factor and retionic acid synergistically activate the inducible prostaglandin synthase gene
3. Alzheimer's disease and non steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2: Rationale and perspectives
4. Effects of interleukin-1 receptor antagonists on the behavioural effects of lipopolysaccharide in rats
5. Defining the role of COX-2 inhibitors in inflammatory and other diseases
6. Expression of FAC1 in activated microglia during Alzeimer's disease
7. Long term ethanol consumption by rats: Effect on acetylcholine release in vivo, choline acetyltransferase activity and behaviour
8. Inflammatory mechanisms in Alzheimer's disease: Inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR gamma agonists
9. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease
10. Age related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain
11. Interleukin 1 regulates synthesis of amuloid beta protein precursor mRNA in human endothelial cells
12. Chronic neuroinflammation in rats reproduce components of the neurobiology of Alzheimer's disease
13. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide
14. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
15. Utility of an elevated plus maze for dissociation of amnesic and behavioral effects of drugs in mice
16. Analgesic, anti-inflammatory and ulcerogenic activity of a zinc-naproxen complex in mice and rats
17. Differential antinociceptive effect of cyclooxygenase inhibitors in acetic acid-induced chemonociception in mice
18. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
19. Potential involvement of the transcription factor NF-kappa B I neurological disorders
20. Increased expression of cyclooxygenase and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains
21. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide 2 synthase
22. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors
23. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other nonsteroidal anti-inflammatory drugs
24. Cyclooxygenase-2 (COX-2) mRNA abundance, stability and hyperactivity in sporadic Alzheimer's neocortex
25. Strong nuclear factor-κB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex
26. 2 release in rats by indomethacin
27. Nonsteroidal anti-inflammatory drug use and Alzheimer type pathology in aging
28. Arthritis and antiinflammatry agents as possible protective factors for Alzheimer's disease: A review of 17 epidemilogic studies
29. Elevated CSF prostaglandin E2 levels in patients with probable AD
30. NF-kappa B: A crucial transcription factor for glial and neuronal cell function
31. Inhibition of inducible nitric oxide synthase gene expression by indomethacin or ibuprofen in β-amyloid protein-stimulated J774 cells
32. Nitric oxide regulates nitric oxide synthase-2 gene expression by initiating NF-kappa B binding to DNA
33. Cyclooxygenase-2 expressions is increased in frontal cortex of Alzheimer's disease brain
34. Cyclopentenone prostaglandins suppress activation of microglia: Down regulation of inducible nitric oxide synthase by 15-deoxy-delta 12,14-prostaglandin J2
35. Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks
36. Possible role nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment
37. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures
38. Risk of Alzheimer's disease and duration of NSAID use
39. New anti-inflammatory treatment strategy in Alzheimer's disease